Evidence map›Paper›PMID 24098554›Full record

ArticlePloS one2013

Alterations of red cell membrane properties in neuroacanthocytosis.

Claudia Siegl, Patricia Hamminger, Herbert Jank, Uwe Ahting, Benedikt Bader, Adrian Danek, Allison Gregory, Monika Hartig, Susan Hayflick, Andreas Hermann and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. PKAN neurodegeneration and residual PANK2 activities in patient erythrocytes.Annals of clinical and translational neurology · 2020
    Article
  10. Article
  11. Chorea-Acanthocytosis and the Huntington Disease Allele in an Irish Family.Tremor and other hyperkinetic movements (New York, N.Y.) · 2018
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 6 countries.

Claudia SieglMax F. Perutz Laboratories, Medical University of Vienna, Vienna, Austria.
Patricia Hamminger
Herbert Jank
Uwe Ahting
Benedikt Bader
Adrian Danek
Allison Gregory
Monika Hartig
Susan Hayflick
Andreas Hermann
Holger Prokisch
Esther M Sammler
Zuhal Yapici
Rainer Prohaska
Ulrich Salzer
Max Perutz Labs · ATOregon Health & Science University · USTechnical University of Munich · DEGerman Center for Neurodegenerative Diseases · DEInstitute of Human Genetics · PLIstanbul University · TRKlinik und Poliklinik für Neurologie · DELudwig-Maximilians-Universität München · DEMedical University of Vienna · ATUniversity of Dundee · GB

Funding

Austrian Science Fund FWF I 438
6 · The paper itself

Abstract

Neuroacanthocytosis (NA) refers to a group of heterogenous, rare genetic disorders, namely chorea acanthocytosis (ChAc), McLeod syndrome (MLS), Huntington's disease-like 2 (HDL2) and pantothenate kinase associated neurodegeneration (PKAN), that mainly affect the basal ganglia and are associated with similar neurological symptoms. PKAN is also assigned to a group of rare neurodegenerative diseases, known as NBIA (neurodegeneration with brain iron accumulation), associated with iron accumulation in the basal ganglia and progressive movement disorder. Acanthocytosis, the occurrence of misshaped erythrocytes with thorny protrusions, is frequently observed in ChAc and MLS patients but less prevalent in PKAN (about 10%) and HDL2 patients. The pathological factors that lead to the formation of the acanthocytic red blood cell shape are currently unknown. The aim of this study was to determine whether NA/NBIA acanthocytes differ in their functionality from normal erythrocytes. Several flow-cytometry-based assays were applied to test the physiological responses of the plasma membrane, namely drug-induced endocytosis, phosphatidylserine exposure and calcium uptake upon treatment with lysophosphatidic acid. ChAc red cell samples clearly showed a reduced response in drug-induced endovesiculation, lysophosphatidic acid-induced phosphatidylserine exposure, and calcium uptake. Impaired responses were also observed in acanthocyte-positive NBIA (PKAN) red cells but not in patient cells without shape abnormalities. These data suggest an "acanthocytic state" of the red cell where alterations in functional and interdependent membrane properties arise together with an acanthocytic cell shape. Further elucidation of the aberrant molecular mechanisms that cause this acanthocytic state may possibly help to evaluate the pathological pathways leading to neurodegeneration.

Indexed as

AcanthocytesAdolescentAdultBasal GangliaCalciumCase-Control StudiesCations, DivalentChildChlorpromazineEndocytosisErythrocyte MembraneFemaleHumansImipramineIon TransportLysophospholipidsCalciumCations, DivalentChlorpromazineImipraminelysophosphatidic acidLysophospholipidsPhosphatidylserinesPrimaquine

Identifiers

PMID24098554
PMCPMC3789665
OpenAlexW2092484308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.